9 Jefferies Group AdaptHealth Trades
Jefferies Group's position in AdaptHealth is currently worth $34.5 Million. That's 0.63% of their equity portfolio (28th largest holding). The investor owns 3.05% of the outstanding AdaptHealth stock. The first AdaptHealth trade was made in Q4 2022. Since then Jefferies Group bought shares five more times and sold shares on three occasions. The investor's estimated purchase price is $40.4 Million, resulting in a loss of 15%.
Avg closing price
Price range
Increased shares by 294.1% (+2.94 Million shares)
Q1 2025
Avg closing price
$10.05
Price range
$8.45
-
$11.38
Sold 43.4% shares (-765 Thousand shares)
Q4 2024
Avg closing price
$10.13
Price range
$9.18
-
$11.00
Increased shares by 5329.1% (+1.73 Million shares)
Q3 2024
Avg closing price
$10.62
Price range
$8.66
-
$11.53
New holding (+32.5 Thousand shares)
Q2 2024
Avg closing price
$10.16
Price range
$9.19
-
$11.60
Sold -11.3 Thousand shares
Q4 2023
Avg closing price
$7.88
Price range
$6.49
-
$9.20
Increased shares by 2.2% (+240 shares)
Q3 2023
Avg closing price
$11.99
Price range
$8.60
-
$14.77
Sold 62.5% shares (-18.4 Thousand shares)
Q2 2023
Avg closing price
$11.14
Price range
$9.43
-
$12.52
Increased shares by 418.0% (+23.7 Thousand shares)
Q1 2023
Avg closing price
$18.40
Price range
$12.43
-
$22.73
New holding (+5.67 Thousand shares)
Q4 2022
Avg closing price
$21.14
Price range
$19.02
-
$23.00
